Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma

Fertility and Sterility

Volumn 86, Issue 4, 2006, Pages 961-971

  Wortham, Noel C ^a   Alam, N Afrina ^a   Barclay, Ella ^a   Pollard, Patrick J ^a   Wagner, Bart E ^c   Manek, Sanjiv ^d   Elia, George ^b   Tomlinson, Ian P M ^a  

^a Regional Molecular Genetics Laboratory   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

apoptosis; HLRCC; mitochondria; ultrastructure; uterine leiomyoma

Indexed keywords

CYCLINE; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER PATIENT; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPE; EXTRACELLULAR MATRIX; FAMILIAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; INTERMEDIATE FILAMENT; KIDNEY CARCINOMA; LEIOMYOMATOSIS; MYOMECTOMY; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS MYOMA;

APOPTOSIS REGULATORY PROTEINS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEIOMYOMA; TISSUE DISTRIBUTION; UTERINE NEOPLASMS;

EID: 33749250917     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.02.106     Document Type: Article

References (38)

1. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30 (2002) 406-410
2. Alam N.A., Rowan A.J., Wortham N.C., Pollard P.J., Mitchell M., Tyrer J.P., et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12 (2003) 1241-1252
3. Pollard P.J., Wortham N.C., and Tomlinson I.P. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med 35 (2003) 632-639
4. Pollard P., Wortham N., Barclay E., Alam A., Elia G., Manek S., et al. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J Pathol 205 (2005) 41-49
5. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
6. Pollard P.J., Briere J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1{alpha} in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14 (2005) 2231-2239
7. Isaacs J.S., Jung Y.J., Mole D.R., Lee S., Torres-Cabala C., Chung Y.L., et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8 (2005) 143-153
8. Brunelle J.K., Santore M.T., Budinger G.R., Tang Y., Barrett T.A., Zong W.X., et al. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1. J Biol Chem 279 (2004) 4305-4312
9. Matsuo H., Kurachi O., Shimomura Y., Samoto T., and Maruo T. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma. Oncology 57 Suppl 2 (1999) 49-58
10. Matsuo H., Maruo T., and Samoto T. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab 82 (1997) 293-299
11. Kovacs K.A., Lengyel F., Kornyei J.L., Vertes Z., Szabo I., Sumegi B., et al. Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 87 (2003) 233-240
12. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., and Mayerhofer K. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig 11 (2004) 187-191
13. Wu X., Blanck A., Olovsson M., Henriksen R., and Lindblom B. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. J Steroid Biochem Mol Biol 80 (2002) 77-83
14. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
15. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644 (2004) 229-249
16. Mikhailov V., Mikhailova M., Degenhardt K., Venkatachalam M.A., White E., and Saikumar P. Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem 278 (2003) 5367-5376
17. Griffiths G.J., Corfe B.M., Savory P., Leech S., Esposti M.D., Hickman J.A., et al. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene 20 (2001) 7668-7676
18. Johnson V.L., Cooper I.R., Jenkins J.R., and Chow S.C. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation, and telomerase activity in Jurkat T cells. Exp Cell Res 251 (1999) 175-184
19. Degenhardt K., Sundararajan R., Lindsten T., Thompson C., and White E. Bax and Bak independently promote cytochrome C release from mitochondria. J Biol Chem 277 (2002) 14127-14134
20. Maruo T., Matsuo H., Shimomura Y., Kurachi O., Gao Z., Nakago S., et al. Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids 68 (2003) 817-824
21. Eyden B. Case for the panel of ultrastructural pathology-uterine leiomyoma. Ultrastruct Pathol 28 (2004) 115-117
22. Eyden B.P., Hale R.J., Richmond I., and Buckley C.H. Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: an ultrastructural and immunohistochemical analysis. Virchows Arch A Pathol Anat Histopathol 420 (1992) 51-58
23. Richards P.A., Richards P.D., and Tiltman A.J. The ultrastructure of fibromyomatous myometrium and its relationship to infertility. Hum Reprod Update 4 (1998) 520-525
24. Erlandson R. Diagnostic transmission electron microscopy of tumors, with clinicopathological, immunohistochemical, and cytogenetic correlations (1994), Raven Press Ltd, New York
25. Ylstra B. Available from: http://www.vumc.nl/microarrays/onderzoek/index.html?protocols.html∼hoofd. Accessed: March 2005.
26. Kim M.M., Clinger J.D., Masayesva B.G., Ha P.K., Zahurak M.L., Westra W.H., et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 10 (2004) 8512-8515
27. Tsushima K., Stanhope C.R., Gaffey T.A., and Lieber M.M. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 63 (1988) 248-255
28. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
29. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
30. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
31. Sasabe E., Tatemoto Y., Li D., Yamamoto T., and Osaki T. Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96 (2005) 394-402
32. Dong Z., and Wang J. Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem 279 (2004) 9215-9221
33. Bures J.C., Barnes L., and Mercer D. A comparative study of smooth muscle tumors utilizing light and electron microscopy, immunocytochemical staining and enzymatic assay. Cancer 48 (1981) 2420-2426
34. Ito F., Kawamura N., Ichimura T., Tsujimura A., Ishiko O., and Ogita S. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment. Fertil Steril 75 (2001) 125-130
35. Leppert P.C., Baginski T., Prupas C., Catherino W.H., Pletcher S., and Segars J.H. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 82 Suppl 3 (2004) 1182-1187
36. Bechet D., Tassa A., Taillandier D., Combaret L., and Attaix D. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 37 (2005) 2098-2114
37. Kroemer G., and Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 5 (2005) 886-897
38. Douwes Dekker P.B., Hogendoorn P.C., Kuipers-Dijkshoorn N., Prins F.A., van Duinen S.G., Taschner P.E., et al. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J Pathol 201 (2003) 480-486